List of SBIR/STTR awards granted to Biomarker Strategies, LLC
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Biomarker Strategies, LLC for $1,498,027.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N91019C00022 | Phase II | 1,498,027 | ||||||||
A SBIR Phase I contract was awarded to Biomarker Strategies, LLC in September, 2017 for $299,340.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA224512-01 | Phase I | 299,340 | September 22, 2017 | |||||||
A SBIR Phase I contract was awarded to Biomarker Strategies, LLC in September, 2015 for $299,876.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44CA203068-01 | Phase I | 299,876 | September 23, 2015 | |||||||
A SBIR Phase II contract was awarded to Biomarker Strategies, LLC in September, 2017 for $1,982,173.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44CA203068-02 | Phase II | 1,982,173 | September 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Biomarker Strategies, LLC for $223,063.0 USD from the U.S. Department of Health & Human Services. | SBIR | 261201600006C-0-0-0 | Phase I | 223,063 | ||||||||
A SBIR Phase II contract was awarded to Biomarker Strategies, LLC for $1,498,569.0 USD from the U.S. Department of Health & Human Services. | SBIR | N44CA130086 | Phase II | 1,498,569 | ||||||||
A SBIR Phase I contract was awarded to Biomarker Strategies, LLC for $1,037,945.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CO090075 | Phase I | 1,037,945 | ||||||||
A SBIR Phase I contract was awarded to Biomarker Strategies, LLC for $192,786.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CO110112 | Phase I | 192,786 | ||||||||
A SBIR Phase I contract was awarded to Biomarker Strategies, LLC for $254,810.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CO200900075 | Phase I | 254,810 |
